Document is current

Documents that mention this clinical trial

Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers
https://doi.org/10.1136/bmjresp-2021-001182

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
https://doi.org/10.1136/bmjresp-2020-000755

β-Blockers are associated with a reduction in COPD exacerbations
https://doi.org/10.1136/thoraxjnl-2015-207251

Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study
https://doi.org/10.1136/bmjresp-2023-002219

Elastic parametric response mapping: quantitative CT scoring for local COPD severity
https://doi.org/10.1136/thorax-2025-223755

Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD
https://doi.org/10.1136/thorax-2024-221928

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years ^{(Pre-results)}
https://doi.org/10.1136/thoraxjnl-2017-210722

Respiratory exacerbations are associated with muscle loss in current and former smokers
https://doi.org/10.1136/thoraxjnl-2020-215999

Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
https://doi.org/10.1136/thoraxjnl-2016-209846

Association of Obesity with Quantitative Chest CT Measured Airway Wall Thickness in WTC Workers with Lower Airway Disease
https://doi.org/10.1007/s00408-019-00246-z

Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts
https://doi.org/10.1136/rmdopen-2024-004281

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
https://doi.org/10.1136/bmjresp-2017-000180

Association between acute respiratory disease events and the <i>MUC5B</i> promoter polymorphism in smokers
https://doi.org/10.1136/thoraxjnl-2017-211208

Documents that mention this clinical trial

Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers
https://doi.org/10.1136/bmjresp-2021-001182

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
https://doi.org/10.1136/bmjresp-2020-000755

β-Blockers are associated with a reduction in COPD exacerbations
https://doi.org/10.1136/thoraxjnl-2015-207251

Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study
https://doi.org/10.1136/bmjresp-2023-002219

Elastic parametric response mapping: quantitative CT scoring for local COPD severity
https://doi.org/10.1136/thorax-2025-223755

Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD
https://doi.org/10.1136/thorax-2024-221928

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years ^{(Pre-results)}
https://doi.org/10.1136/thoraxjnl-2017-210722

Respiratory exacerbations are associated with muscle loss in current and former smokers
https://doi.org/10.1136/thoraxjnl-2020-215999

Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
https://doi.org/10.1136/thoraxjnl-2016-209846

Association of Obesity with Quantitative Chest CT Measured Airway Wall Thickness in WTC Workers with Lower Airway Disease
https://doi.org/10.1007/s00408-019-00246-z

Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts
https://doi.org/10.1136/rmdopen-2024-004281

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
https://doi.org/10.1136/bmjresp-2017-000180

Association between acute respiratory disease events and the <i>MUC5B</i> promoter polymorphism in smokers
https://doi.org/10.1136/thoraxjnl-2017-211208

Documents that mention this clinical trial

Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers
https://doi.org/10.1136/bmjresp-2021-001182

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
https://doi.org/10.1136/bmjresp-2020-000755

β-Blockers are associated with a reduction in COPD exacerbations
https://doi.org/10.1136/thoraxjnl-2015-207251

Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study
https://doi.org/10.1136/bmjresp-2023-002219

Elastic parametric response mapping: quantitative CT scoring for local COPD severity
https://doi.org/10.1136/thorax-2025-223755

Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD
https://doi.org/10.1136/thorax-2024-221928

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years ^{(Pre-results)}
https://doi.org/10.1136/thoraxjnl-2017-210722

Respiratory exacerbations are associated with muscle loss in current and former smokers
https://doi.org/10.1136/thoraxjnl-2020-215999

Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
https://doi.org/10.1136/thoraxjnl-2016-209846

Association of Obesity with Quantitative Chest CT Measured Airway Wall Thickness in WTC Workers with Lower Airway Disease
https://doi.org/10.1007/s00408-019-00246-z

Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts
https://doi.org/10.1136/rmdopen-2024-004281

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
https://doi.org/10.1136/bmjresp-2017-000180

Association between acute respiratory disease events and the <i>MUC5B</i> promoter polymorphism in smokers
https://doi.org/10.1136/thoraxjnl-2017-211208